109
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Low-dose spiruchostatin-B, a potent histone deacetylase inhibitor enhances radiation-induced apoptosis in human lymphoma U937 cells via modulation of redox signaling

, , , , , , & show all
Pages 596-610 | Received 14 Sep 2015, Accepted 27 Oct 2015, Published online: 24 Apr 2016

References

  • Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot (Tokyo) 1994;47:301–310.
  • Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, et al. Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther 2010;10:997–1008.
  • Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood 2011;117:5827–5834.
  • Shah MH, Binkley P, Chan K, Xiao J, Arbogast D, Collamore M, et al. Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clin Cancer Res 2006;12:3997–4003.
  • Kano Y, Akutsu M, Tsunoda S, Izumi T, Kobayashi H, Mano H, Furukawa Y. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines. Invest New Drugs 2007; 25:31–40.
  • George-Yurek A, Cecil AR, Mo AH, Wen S, Rogers H, Habens F, et al. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. J Med Chem 2007;50:5720–5726.
  • Witt O, Deubzer HE, Milde T, Oehme I. HDAC family: what are the cancer relevant targets? Cancer Lett 2009; 277:8–21.
  • Narita K, Kikuchi T, Watanabe K, Takizawa T, Oguchi T, Kudo K, et al. Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 500-epispiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity. Chem Eur J 2009;15:11174–11186.
  • Rehman MU, Jawaid P, Yoshihisa Y, Li P, Zhao QL, Narita K, et al. Spiruchostatin A and B, novel histone deacetylase inhibitors, induce apoptosis through reactive oxygen species-mitochondria pathway in human lymphoma U937 cells. Chem Biol Interact 2014; 221:24–34.
  • Borek C. Antioxidants and radiation therapy. J Nutr 2004;134:3207–3209.
  • Szostak MJ, Kyprianou N. Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer. Oncol Rep 2000;7:699–706.
  • Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg 2014;133:49 e–56 e.
  • Verhei M, Vens C, Van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective. Drug Resist Updat 2010;13:29–43.
  • Chinnaiyan P, Cerna D, Burgan WE, Beam K, Williams ES, Camphausen K, Tofilon PJ. Postradiation sensitization of the histone deacetylase inhibitor valporic acid. Clin Cancer Res 2008;14:5410–5415.
  • Samuni Y, Wink DA, Krishna MC, Mitchell JB, Goldstein S. Suberoylanilide hydroxamic acid radio-sensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide. Free Radical Biol Med 2014;73:291–298.
  • Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl) amino-methyl] benzamide, and m-carboxycinnamic acid bis-hydroximade augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer 2004;110:301–308.
  • Camphausen K, Burgan WE, Cerra M, Oawald KA, Trepel JB, Lee MJ, Tofilon PJ. Enhanced radiation- induced cell killing and prolongation of gamma- H2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 2004; 64:316–321.
  • Sellins KS, Cohen JJ. Gene induction by gamma irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;139:3199–3206.
  • Setsukinai KI, Urano Y, Kakinumas K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect Reactive oxygen species and distinguish specific species. J Biol Chem 2003;278:3170–3175.
  • Jawaid P, Rehman MU, Yoshihisa Y, Li P, Zhao QL, Hassan MA, et al. Effects of SOD/catalase mimetic platinum nanoparticles on radiation-induced apoptosis in human lymphoma U937 cells. Apoptosis 2014;19:1006–1016.
  • Marks P, Rifkind R, Richon V, Breslow R, Miller T, Kelly W. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001; 1:194–202.
  • Pettazzoni P, Pizzimenti S, Toaldo C, Sotomayor P, Tagliavacca L, Liu S, et al. Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. Free Radical Biol Med 2011;50:313–322.
  • Dewey WC, Noel JS, Dettor CM. Changes in radiosensitivity and dispersion of chromatin during the cell cycle of synchronous Chinese hamster cells. Radiat Res 1972;52:373–394.
  • Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 2005;11: 4912–4922.
  • Mizutani H, Hiraku Y, Oikawa ST, Murata M, Ikemura K, Iwamoto T, et al. Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. Cancer Sci 2010;101:2214–2219.
  • Riley PA. Free radical in biology: oxidative stress and the effects of ionization radiation. Int.J Radiat Biol 1994; 65:27–33.
  • Zhang X, Zhou X, Chen R, Zhang H. Radiosensitization by inhibiting complex I activity in human hepatoma HepG2 cells to X-ray radiation. J Radiat Res 2012; 53:257–263.
  • Hall EJ. The physics and chemistry of radiation absorption. In: Mitchell CW, ed. Radiobiology for the radiologist. 7th ed. New York: Lippincott for Williams and Wilkins; 2012. 1–16 p.
  • Cui ZG, Kondo T, Feril J LB, Waki K, Inanami O, Kuwabara M. Effects of antioxidants on x-ray or hyperthermia induced apoptosis in human lymphoma U937 cells. Apoptosis 2004;9:757–763.
  • Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanism in cancer patients and the human population. J Am Coll Nutr 2001;20:464 S–475S.
  • Hall EJ. Oxygen Effect and Reoxygenation. In: Mitchell CW, ed. Radiobiology for the Radiologist, 7th ed. New York: Lipponcott for Williams and Wilkins; 2012. 86–103 p.
  • Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858–5868.
  • Paul TT, Rogakou EP, Yamazaki V, Kirchqessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886–895.
  • Kawano T, Akiyama M, Agawa-Ohta M, Mikami-Terao Y, Iwase S, Yanagisawa T, et al. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. Int J Oncol 2010;37:787–795.
  • Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Histone deacetylase inhibitors FK228, -(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer 2004;110:301–308.
  • Strasser A, Newton K. FADD/MORT1, a signal transducer that can promote cell death or cell growth. Int J Biochem Cell Biol 1999; 31:533–537.
  • Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family protein, connects the death receptor and mitochondria apoptosis pathways. Cell Res 2000;10:161–167.
  • Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922–2933.
  • Hori T, Kondo T, Kanamori M, Tabuchi Y, Ogawa R, Zhao QL, et al. Ionizing radiation enhances tumor necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor (DR5) in human osteosarcoma cells. J Orthop Res 2010;28:739–745.
  • Yu DY, Zhao QL, Wei ZL, Nomura T, Kashiwakura I, Kagiya TV, Kondo T. Enhancement of radiation induced apoptosis of human lymphoma U937 cells by sanazole. Apoptosis 2009;14:655–664.
  • Nutt LK, Chandra J, Pataer A, Fang B, Roth JA, Swisher SG, et al. Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis. J Biol Chem 2002; 277:20301–20308.
  • Cui ZG, Kondo T, Ogawa R, Feril LB JR, Zhao QL, Wada S, et al. Enhancement of radiation-induced apoptosis by 6-formylpterin. Free Radic Res 2004;38:363–373.
  • Hui KF, Chiang AK. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER-stress-induced mechanism. Int J Cancer 2014;135:2950–2961.
  • Chen X, Wong JY, Wong P, Randany EH. Low dose valporic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis. Mol Cancer Res 2011;4:448–461.
  • Lee YJ, Chung DY, Lee SJ, Ja Jhon G, Lee YS. Enhanced radio-sensitization of p53 mutant cells by oleamide. Int J Radiat Oncol Biol Phys 2006; 64:1466–1474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.